查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2038778

連續血糖監測市場商機、成長要素、產業趨勢分析及2026-2035年預測。

Continuous Glucose Monitoring Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 142 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球連續血糖監測市場價值為 124 億美元，預計到 2035 年將達到 555 億美元，年複合成長率為 16.3%。

連續血糖監測市場-IMG1

市場擴張的促進因素包括：全球糖尿病負擔日益加重、對即時血糖值監測解決方案的需求不斷成長、穿戴式醫療技術的持續進步，以及旨在提高糖尿病認知和管理水平的公共衛生舉措的增加。隨著患者和醫療專業人員轉向數據驅動的治療方法，對精準、持續監測工具的需求不斷成長，正在改變糖尿病照護模式。感測器小型化、無線連接和行動整合的技術進步進一步提升了設備的易用性和臨床效率。持續血糖監測（CGM）系統因其能夠提供血糖值波動的即時訊息，並有助於減少因檢測延遲而引起的併發症，而備受關注。遠距醫療和居家照護模式的日益普及也推動了市場滲透率的提升。此外，醫療服務可近性的提高、報銷制度的完善以及病患教育水準的提高，都在推動已開發市場和新興醫療市場對CGM系統的使用。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 124億美元
預計金額 555億美元
複合年成長率 16.3%

預計到2025年，基於感測器的監測設備市場規模將達到63億美元。由於感測器精度、耐用性和整體性能的不斷提升，該市場持續成長。現代感測器技術顯著提高了測量精度，先進系統的平均絕對相對誤差已低於10%。此外，小型化技術的進步提高了患者的舒適度，使長期使用更加便捷，也更容易被廣泛接受。這些進步進一步鞏固了基於感測器的設備在連續可靠血糖值監測中的作用。

預計到2025年，居家照護環境市場規模將達到101億美元。隨著患者現在可以在臨床環境之外即時監測血糖值，該領域的應用正在加速成長。這些設備能夠及早發現血糖值異常波動，從而支持主動式糖尿病管理，並減少患者對醫院就診的依賴。在醫療服務分散化的背景下，持續血糖監測（CGM）解決方案在長期糖尿病管理、治療後監測和老年護理等領域的應用正在加速成長，因為在這些領域，持續監測對於預防併發症至關重要。

預計2025年，美國持續血糖監測（CGM）市場規模將達57億美元。該國市場成長的主要促進因素包括高昂的醫療費用支出、先進醫療技術的普及以及糖尿病患者人數的不斷成長。數位健康解決方案和持續監測設備的日益普及也進一步推動了市場擴張。此外，優惠的報銷政策提高了CGM系統的可及性，促進了更廣泛的患者群體使用，並增強了整體市場前景。

目錄

第1章：調查方法

  • 研究途徑
  • 品質改進計劃
    • GMI人工智慧政策及對資料完整性的承諾
      • 資訊來源一致性協議
  • 調查過程和可靠性評分
    • 調查過程的組成部分
    • 評分組成部分
  • 數據收集
    • 主要來源部分列表
  • 資料探勘資訊來源
    • 付費資訊來源
      • 區域資訊來源
  • 基本估算和計算方法
    • 每種方法中基準年的計算
  • 預測模型
    • 量化市場影響分析
      • 生長參數對預測的數學影響
  • 關於調查透明度的補充信息
    • 資訊來源歸屬框架
    • 品質保證指標
    • 對信任的承諾

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 影響產業的因素
    • 促進因素
      • 全球糖尿病盛行率正在上升。
      • 對連續監測設備的需求日益成長
      • 設備技術進步
      • 政府加強意識提升。
    • 產業潛在風險與挑戰
      • 設備相關的高成本
      • 嚴格的法規環境
    • 市場機遇
      • 新興市場的擴張
  • 成長潛力分析
  • 監理情勢（基於初步調查）
    • 北美洲
    • 歐洲
    • 亞太地區
  • 技術趨勢（基於初步調查）
    • 目前技術
      • 即時連續血糖監測系統
      • 具備藍牙功能的 CGM 感測器和發射器
      • 行動應用程式和基於雲端的 CGM 資料平台
    • 新興技術
      • 人工智慧驅動的血糖值預測和決策支援演算法
      • 非侵入性和微創血糖感測技術
      • 可長期配戴且相容多天使用的 CGM 感光元件
      • 一個完全整合的數位化糖尿病管理生態系統
  • 未來市場趨勢（基於初步研究）
  • 專利分析（基於初步研究）
  • 價格分析（2025 年）（基於初步調查）
  • 人工智慧和生成式人工智慧對市場的影響（基於初步研究）
  • 波特五力分析
  • PESTEL 分析

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
  • 企業矩陣分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 業務拓展計劃

第5章 市場估計與預測：依組件分類，2022-2035年

  • 發送器
  • 感應器
  • 接收器

第6章 市場估算與預測：依最終用途分類，2022-2035年

  • 醫院
  • 居家照護設施
  • 診斷中心和診所
  • 其他最終用戶

第7章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第8章：公司簡介

  • Abbott Laboratories
  • A. Menarini Diagnostics
  • Dexcom
  • i-SENS
  • F. Hoffmann-La Roche
  • Med Trust
  • Medtronic
  • Medtrum Technologies
  • Senseonics
  • Sinocare
  • Zhejiang POCTech
簡介目錄
Product Code: 6109

The Global Continuous Glucose Monitoring Market was valued at USD 12.4 billion in 2025 and is estimated to grow at a CAGR of 16.3% to reach USD 55.5 billion by 2035.

Continuous Glucose Monitoring Market - IMG1

Market expansion is influenced by the escalating global burden of diabetes, rising preference for real-time glucose tracking solutions, continuous improvements in wearable medical technologies, and increasing public health initiatives aimed at diabetes awareness and management. Growing demand for accurate and continuous monitoring tools is reshaping diabetes care, as patients and healthcare providers shift toward data-driven treatment approaches. Technological progress in sensor miniaturization, wireless connectivity, and mobile integration is further enhancing device usability and clinical efficiency. Continuous glucose monitoring systems are gaining traction as they provide real-time insights into glucose fluctuations, helping reduce complications associated with delayed detection. Increasing adoption of remote and home-based care models is also supporting market penetration. Additionally, expanding healthcare access, improved reimbursement frameworks, and rising patient education levels are encouraging wider utilization of CGM systems across both developed and emerging healthcare markets.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$12.4 Billion
Forecast Value$55.5 Billion
CAGR16.3%

The sensor-based monitoring devices segment accounted for USD 6.3 billion in 2025. This segment continues to expand due to ongoing improvements in sensor precision, durability, and overall performance. Modern sensor technologies have significantly enhanced measurement accuracy, with advanced systems achieving a mean absolute relative difference below 10%. Enhanced miniaturization has also improved patient comfort, making long-term usage more practical and widely accepted. These advancements are strengthening the role of sensor-based devices in continuous and reliable glucose tracking.

The home care settings segment reached USD 10.1 billion in 2025. Adoption in this segment is increasing as continuous glucose monitoring systems enable patients to track glucose levels in real time outside clinical environments. These devices support proactive diabetes management by allowing early identification of abnormal glucose fluctuations and reducing dependence on hospital visits. The growing shift toward decentralized healthcare delivery is accelerating the use of CGM solutions for long-term diabetes management, post-treatment monitoring, and elderly care, where continuous observation is essential for preventing complications.

U.S. Continuous Glucose Monitoring Market reached USD 5.7 billion in 2025. Market growth in the country is supported by high healthcare expenditure, strong availability of advanced medical technologies, and a rising diabetes population. Increasing adoption of digital health solutions and continuous monitoring devices is further contributing to market expansion. Favorable reimbursement frameworks have also improved access to CGM systems, enabling broader patient adoption and strengthening the overall market outlook.

Leading players such as Abbott Laboratories, Dexcom, Medtronic, Senseonics, F. Hoffmann-La Roche, A. Menarini Diagnostics, i-SENS, Medtrum Technologies, Med Trust, Sinocare, and Zhejiang POCTech continue to focus on product innovation and global expansion strategies to reinforce their competitive position. Companies in the Continuous Glucose Monitoring Market are focusing on continuous innovation in sensor accuracy, device miniaturization, and longer sensor lifespan to improve patient compliance and clinical reliability. They are expanding integration with smartphones and digital health platforms to enhance real-time data access and remote monitoring capabilities. Strategic collaborations with healthcare providers and insurers are helping improve reimbursement coverage and market accessibility. Manufacturers are also investing heavily in research and development to enhance algorithm-driven glucose prediction and improve user experience. Additionally, companies are strengthening global distribution networks and increasing investments in emerging markets to expand patient reach and accelerate adoption of advanced diabetes management solutions.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
    • 2.1.1 Key market trends
    • 2.1.2 Component trends
    • 2.1.3 End use trends
    • 2.1.4 Regional trends
  • 2.2 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of diabetes, globally
      • 3.2.1.2 Rising demand for continuous monitoring devices
      • 3.2.1.3 Technological advancements in devices
      • 3.2.1.4 Increasing government initiatives to generate awareness regarding diabetes
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost related to devices
      • 3.2.2.2 Stringent regulatory scenario
    • 3.2.3 Market opportunity
      • 3.2.3.1 Expansion in emerging markets
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape (Driven by Primary Research)
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technological landscape (Driven by Primary Research)
    • 3.5.1 Current technologies
      • 3.5.1.1 Real time continuous glucose monitoring systems
      • 3.5.1.2 Bluetooth enabled CGM sensors and transmitters
      • 3.5.1.3 Mobile apps and cloud based CGM data platforms
    • 3.5.2 Emerging technologies
      • 3.5.2.1 AI driven glucose prediction and decision-support algorithms
      • 3.5.2.2 Non invasive and minimally invasive glucose sensing technologies
      • 3.5.2.3 Extended wear and multi-day CGM sensors
      • 3.5.2.4 Fully integrated digital diabetes management ecosystems
  • 3.6 Future market trends (Driven by Primary Research)
  • 3.7 Patent analysis (Driven by Primary Research)
  • 3.8 Pricing analysis, 2025 (Driven by Primary Research)
  • 3.9 Impact of AI and Generative AI on the market (Driven by Primary Research)
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Merger and acquisition
    • 4.6.2 Partnership and collaboration
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Component, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Transmitters
  • 5.3 Sensors
  • 5.4 Receivers

Chapter 6 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Home care settings
  • 6.4 Diagnostic centres and clinics
  • 6.5 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Abbott Laboratories
  • 8.2 A. Menarini Diagnostics
  • 8.3 Dexcom
  • 8.4 i-SENS
  • 8.5 F. Hoffmann-La Roche
  • 8.6 Med Trust
  • 8.7 Medtronic
  • 8.8 Medtrum Technologies
  • 8.9 Senseonics
  • 8.10 Sinocare
  • 8.11 Zhejiang POCTech